Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study ; volume:240 ; number:7 ; day:24 ; month:5 ; year:2023 ; pages:1547-1560 ; date:7.2023
Psychopharmacology ; 240, Heft 7 (24.5.2023), 1547-1560, 7.2023
- Urheber
-
Breeksema, Joost J.
Niemeijer, Alistair
Kuin, Bouwe
Veraart, Jolien
Vermetten, Eric
Kamphuis, Jeanine
Brink, Wim van den
Schoevers, Robert
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-023-06388-6
- URN
-
urn:nbn:de:101:1-2023092113012662000831
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Breeksema, Joost J.
- Niemeijer, Alistair
- Kuin, Bouwe
- Veraart, Jolien
- Vermetten, Eric
- Kamphuis, Jeanine
- Brink, Wim van den
- Schoevers, Robert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
A Novel Treatment Approach to Treatment-Resistant, Recurrent Clostridium difficile
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Treatment-resistant depression: molecular mechanisms and management
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
A Novel Treatment Approach to Treatment-Resistant, Recurrent Clostridium difficile
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Treatment-resistant depression: molecular mechanisms and management
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders : a case report
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
A Novel Treatment Approach to Treatment-Resistant, Recurrent Clostridium difficile
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment